BMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertension

Cell Metabolism

Volumn 21, Issue 4, 2015, Pages 596-608

  Diebold, Isabel ^a   Hennigs, Jan K ^a   Miyagawa, Kazuya ^a   Li, Caiyun G ^a   Nickel, Nils P ^a   Kaschwich, Mark ^a   Cao, Aiqin ^a   Wang, Lingli ^a   Reddy, Sushma ^a   Chen, Pin I ^a   Nakahira, Kiichi ^b   Alcazar, Miguel A Alejandre ^a   Hopper, Rachel K ^a   Ji, Lijuan ^a   Feldman, Brian J ^a   Rabinovitch, Marlene ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; MITOCHONDRIAL DNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN P53; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; BMPR2 PROTEIN, MOUSE; DNA; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOGENESIS; CELL SURVIVAL; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; ENDOTHELIUM CELL; ENERGY METABOLISM; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; HYPOXIA-INDUCED PULMONARY HYPERTENSION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REOXYGENATION; ANALYSIS OF VARIANCE; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HEK293 CELL LINE; METABOLISM; MITOCHONDRION; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PULMONARY ARTERY; PULMONARY HYPERTENSION; REGENERATION; WESTERN BLOTTING;

MUS;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CELL SURVIVAL; DNA; DNA PRIMERS; ENDOTHELIAL CELLS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HEK293 CELLS; HUMANS; HYPERTENSION, PULMONARY; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIA; MODELS, BIOLOGICAL; POLYMERASE CHAIN REACTION; PULMONARY ARTERY; REGENERATION; RNA, SMALL INTERFERING;

EID: 84928404144     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2015.03.010     Document Type: Article

References (62)

1. T.P. Alastalo, M. Li, J. Perez Vde, D. Pham, H. Sawada, J.K. Wang, M. Koskenvuo, L. Wang, B.A. Freeman, H.Y. Chang, and M. Rabinovitch Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival J. Clin. Invest. 121 2011 3735 3746
2. K. Aquilano, S. Baldelli, B. Pagliei, S.M. Cannata, G. Rotilio, and M.R. Ciriolo p53 orchestrates the PGC-1alpha-mediated antioxidant response upon mild redox and metabolic imbalance Antioxid. Redox. Signal. 18 2013 386 399
3. S.L. Archer, M. Gomberg-Maitland, M.L. Maitland, S. Rich, J.G. Garcia, and E.K. Weir Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer Am. J. Physiol. Heart Circ. Physiol. 294 2008 H570 H578
4. S.L. Archer, G. Marsboom, G.H. Kim, H.J. Zhang, P.T. Toth, E.C. Svensson, J.R. Dyck, M. Gomberg-Maitland, B. Thébaud, and A.N. Husain Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target Circulation 121 2010 2661 2671
5. C. Atkinson, S. Stewart, P.D. Upton, R. Machado, J.R. Thomson, R.C. Trembath, and N.W. Morrell Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor Circulation 105 2002 1672 1678
6. S. Bonnet, E.D. Michelakis, C.J. Porter, M.A. Andrade-Navarro, B. Thébaud, S. Bonnet, A. Haromy, G. Harry, R. Moudgil, and M.S. McMurtry An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension Circulation 113 2006 2630 2641
7. V.J. Burton, A.M. Holmes, L.I. Ciuclan, A. Robinson, J.S. Roger, G. Jarai, A.C. Pearce, and D.C. Budd Attenuation of leukocyte recruitment via CXCR1/2 inhibition stops the progression of PAH in mice with genetic ablation of endothelial BMPR-II Blood 118 2011 4750 4758
8. T. Chen, J. He, L. Shen, H. Fang, H. Nie, T. Jin, X. Wei, Y. Xin, Y. Jiang, and H. Li The mitochondrial DNA 4,977-bp deletion and its implication in copy number alteration in colorectal cancer BMC Med. Genet. 12 2011 8
9. Y. Cheng, X. Ren, A.S. Gowda, Y. Shan, L. Zhang, Y.S. Yuan, R. Patel, H. Wu, K. Huber-Keener, and J.W. Yang Interaction of Sirt3 with OGG1 contributes to repair of mitochondrial DNA and protects from apoptotic cell death under oxidative stress Cell Death Dis. 4 2013 e731
10. H.J. Chun, Z.A. Ali, Y. Kojima, R.K. Kundu, A.Y. Sheikh, R. Agrawal, L. Zheng, N.J. Leeper, N.E. Pearl, and A.J. Patterson Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis J. Clin. Invest. 118 2008 3343 3354
11. O. Culic, M.L. Gruwel, and J. Schrader Energy turnover of vascular endothelial cells Am. J. Physiol. 273 1997 C205 C213
12. R.J. Davies, A.M. Holmes, J. Deighton, L. Long, X. Yang, L. Barker, C. Walker, D.C. Budd, P.D. Upton, and N.W. Morrell BMP type II receptor deficiency confers resistance to growth inhibition by TGF-beta in pulmonary artery smooth muscle cells: role of proinflammatory cytokines Am. J. Physiol. Lung Cell. Mol. Physiol. 302 2012 L604 L615
13. Z. Deng, J.H. Morse, S.L. Slager, N. Cuervo, K.J. Moore, G. Venetos, S. Kalachikov, E. Cayanis, S.G. Fischer, and R.J. Barst Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene Am. J. Hum. Genet. 67 2000 737 744
14. I. Diebold, T. Djordjevic, A. Petry, A. Hatzelmann, H. Tenor, J. Hess, and A. Görlach Phosphodiesterase 2 mediates redox-sensitive endothelial cell proliferation and angiogenesis by thrombin via Rac1 and NADPH oxidase 2 Circ. Res. 104 2009 1169 1177
15. S. Duvezin-Caubet, R. Jagasia, J. Wagener, S. Hofmann, A. Trifunovic, A. Hansson, A. Chomyn, M.F. Bauer, G. Attardi, and N.G. Larsson Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology J. Biol. Chem. 281 2006 37972 37979
16. J.P. Fessel, C.R. Flynn, L.J. Robinson, N.L. Penner, S. Gladson, C.J. Kang, D.H. Wasserman, A.R. Hemnes, and J.D. West Hyperoxia synergizes with mutant bone morphogenic protein receptor 2 to cause metabolic stress, oxidant injury, and pulmonary hypertension Am. J. Respir. Cell Mol. Biol. 49 2013 778 787
17. I. Fijalkowska, W. Xu, S.A. Comhair, A.J. Janocha, L.A. Mavrakis, B. Krishnamachary, L. Zhen, T. Mao, A. Richter, S.C. Erzurum, and R.M. Tuder Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells Am. J. Pathol. 176 2010 1130 1138
18. S. Frank, B. Gaume, E.S. Bergmann-Leitner, W.W. Leitner, E.G. Robert, F. Catez, C.L. Smith, and R.J. Youle The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis Dev. Cell 1 2001 515 525
19. R.J. Giedt, C. Yang, J.L. Zweier, A. Matzavinos, and B.R. Alevriadou Mitochondrial fission in endothelial cells after simulated ischemia/reperfusion: role of nitric oxide and reactive oxygen species Free Radic. Biol. Med. 52 2012 348 356
20. S.E. Gill, R. Taneja, M. Rohan, L. Wang, and S. Mehta Pulmonary microvascular albumin leak is associated with endothelial cell death in murine sepsis-induced lung injury in vivo PLoS ONE 9 2014 e88501
21. C. Guignabert, C.M. Alvira, T.P. Alastalo, H. Sawada, G. Hansmann, M. Zhao, L. Wang, N. El-Bizri, and M. Rabinovitch Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization Am. J. Physiol. Lung Cell. Mol. Physiol. 297 2009 L1082 L1090
22. G. Hansmann, V.A. de Jesus Perez, T.P. Alastalo, C.M. Alvira, C. Guignabert, J.M. Bekker, S. Schellong, T. Urashima, L. Wang, N.W. Morrell, and M. Rabinovitch An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension J. Clin. Invest. 118 2008 1846 1857
23. K.S. Heo, H. Lee, P. Nigro, T. Thomas, N.T. Le, E. Chang, C. McClain, C.A. Reinhart-King, M.R. King, and B.C. Berk PKCζ mediates disturbed flow-induced endothelial apoptosis via p53 SUMOylation J. Cell Biol. 193 2011 867 884
24. J.R. Howe, J.L. Bair, M.G. Sayed, M.E. Anderson, F.A. Mitros, G.M. Petersen, V.E. Velculescu, G. Traverso, and B. Vogelstein Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis Nat. Genet. 28 2001 184 187
25. F.N. Jilwan, P. Escourrou, G. Garcia, X. Jaïs, M. Humbert, and G. Roisman High occurrence of hypoxemic sleep respiratory disorders in precapillary pulmonary hypertension and mechanisms Chest 143 2013 47 55
26. M.W. Julian, G. Shao, Z.C. Vangundy, T.L. Papenfuss, and E.D. Crouser Mitochondrial transcription factor A, an endogenous danger signal, promotes TNFα release via RAGE- and TLR9-responsive plasmacytoid dendritic cells PLoS ONE 8 2013 e72354
27. Y.M. Kim, L. Haghighat, E. Spiekerkoetter, H. Sawada, C.M. Alvira, L. Wang, S. Acharya, G. Rodriguez-Colon, A. Orton, M. Zhao, and M. Rabinovitch Neutrophil elastase is produced by pulmonary artery smooth muscle cells and is linked to neointimal lesions Am. J. Pathol. 179 2011 1560 1572
28. J. Kim, Y. Kang, Y. Kojima, J.K. Lighthouse, X. Hu, M.A. Aldred, D.L. McLean, H. Park, S.A. Comhair, and D.M. Greif An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension Nat. Med. 19 2013 74 82
29. K.B. Lane, R.D. Machado, M.W. Pauciulo, J.R. Thomson, J.A. Phillips 3rd, J.E. Loyd, W.C. Nichols, R.C. Trembath International PPH Consortium Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension Nat. Genet. 26 2000 81 84
30. K.L. Lane, M. Talati, E. Austin, A.R. Hemnes, J.A. Johnson, J.P. Fessel, T. Blackwell, R.L. Mernaugh, L. Robinson, and C. Fike Oxidative injury is a common consequence of BMPR2 mutations Pulm. Circ. 1 2011 72 83
31. N.G. Larsson, J. Wang, H. Wilhelmsson, A. Oldfors, P. Rustin, M. Lewandoski, G.S. Barsh, and D.A. Clayton Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice Nat. Genet. 18 1998 231 236
32. M. Li, S.R. Riddle, M.G. Frid, K.C. El Kasmi, T.A. McKinsey, R.J. Sokol, D. Strassheim, B. Meyrick, M.E. Yeager, and A.R. Flockton Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension J. Immunol. 187 2011 2711 2722
33. F.A. Masri, W. Xu, S.A. Comhair, K. Asosingh, M. Koo, A. Vasanji, J. Drazba, B. Anand-Apte, and S.C. Erzurum Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension Am. J. Physiol. Lung Cell. Mol. Physiol. 293 2007 L548 L554
34. G.M. Matuschak, C.F. Munoz, C.A. Johanns, R. Rahman, and A.J. Lechner Upregulation of postbacteremic TNF-alpha and IL-1alpha gene expression by alveolar hypoxia/reoxygenation in perfused rat lungs Am. J. Respir. Crit. Care Med. 157 1998 629 637
35. M.S. McMurtry, S. Bonnet, X. Wu, J.R. Dyck, A. Haromy, K. Hashimoto, and E.D. Michelakis Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis Circ. Res. 95 2004 830 840
36. E.D. Michelakis, V. Hampl, A. Nsair, X. Wu, G. Harry, A. Haromy, R. Gurtu, and S.L. Archer Diversity in mitochondrial function explains differences in vascular oxygen sensing Circ. Res. 90 2002 1307 1315
37. E.D. Michelakis, M.S. McMurtry, X.C. Wu, J.R. Dyck, R. Moudgil, T.A. Hopkins, G.D. Lopaschuk, L. Puttagunta, R. Waite, and S.L. Archer Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels Circulation 105 2002 244 250
38. S. Mizuno, H.J. Bogaard, D. Kraskauskas, A. Alhussaini, J. Gomez-Arroyo, N.F. Voelkel, and T. Ishizaki p53 gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice Am. J. Physiol. Lung Cell. Mol. Physiol. 300 2011 L753 L761
39. N. Mouraret, E. Marcos, S. Abid, G. Gary-Bobo, M. Saker, A. Houssaini, J.L. Dubois-Rande, L. Boyer, J. Boczkowski, and G. Derumeaux Activation of lung p53 by Nutlin-3a prevents and reverses experimental pulmonary hypertension Circulation 127 2013 1664 1676
40. J. O'Prey, D. Crighton, A.G. Martin, K.H. Vousden, H.O. Fearnhead, and K.M. Ryan p53-mediated induction of Noxa and p53AIP1 requires NFkappaB Cell Cycle 9 2010 947 952
41. K.H. Park, T.H. Lee, C.W. Kim, and J. Kim Enhancement of CCL15 expression and monocyte adhesion to endothelial cells (ECs) after hypoxia/reoxygenation and induction of ICAM-1 expression by CCL15 via the JAK2/STAT3 pathway in ECs J. Immunol. 190 2013 6550 6558
42. F. Potus, S. Malenfant, C. Graydon, V. Mainguy, È. Tremblay, S. Breuils-Bonnet, F. Ribeiro, A. Porlier, F. Maltais, S. Bonnet, and S. Provencher Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension Am. J. Respir. Crit. Care Med. 190 2014 318 328
43. M. Rabinovitch, W.J. Gamble, O.S. Miettinen, and L. Reid Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery Am. J. Physiol. 240 1981 H62 H72
44. G.C. Rowe, A. Jiang, and Z. Arany PGC-1 coactivators in cardiac development and disease Circ. Res. 107 2010 825 838
45. J.J. Ryan, G. Marsboom, Y.H. Fang, P.T. Toth, E. Morrow, N. Luo, L. Piao, Z. Hong, K. Ericson, and H.J. Zhang PGC1α-mediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertension Am. J. Respir. Crit. Care Med. 187 2013 865 878
46. S. Sakao, K. Tatsumi, and N.F. Voelkel Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation Respir. Res. 10 2009 95
47. H. Sawada, T. Saito, N.P. Nickel, T.P. Alastalo, J.P. Glotzbach, R. Chan, L. Haghighat, G. Fuchs, M. Januszyk, and A. Cao Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension J. Exp. Med. 211 2014 263 280
48. N. Sawada, A. Jiang, F. Takizawa, A. Safdar, A. Manika, Y. Tesmenitsky, K.T. Kang, J. Bischoff, H. Kalwa, and J.L. Sartoretto Endothelial PGC-1α mediates vascular dysfunction in diabetes Cell Metab. 19 2014 246 258
49. R.C. Scarpulla Transcriptional paradigms in mammalian mitochondrial biogenesis and function Physiol. Rev. 88 2008 611 638
50. Y. Shimasaki, N. Pan, L.M. Messina, C. Li, K. Chen, L. Liu, M.P. Cooper, J.A. Vita, and J.F. Keaney Jr. Uncoupling protein 2 impacts endothelial phenotype via p53-mediated control of mitochondrial dynamics Circ. Res. 113 2013 891 901
51. E. Spiekerkoetter, X. Tian, J. Cai, R.K. Hopper, D. Sudheendra, C.G. Li, N. El-Bizri, H. Sawada, R. Haghighat, and R. Chan FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension J. Clin. Invest. 123 2013 3600 3613
52. G. Sutendra, and E.D. Michelakis The metabolic basis of pulmonary arterial hypertension Cell Metab. 19 2014 558 573
53. G. Sutendra, S. Bonnet, G. Rochefort, A. Haromy, K.D. Folmes, G.D. Lopaschuk, J.R. Dyck, and E.D. Michelakis Fatty acid oxidation and malonyl-CoA decarboxylase in the vascular remodeling of pulmonary hypertension Sci. Transl. Med. 2 2010 44ra58
54. G. Sutendra, P. Dromparis, S. Bonnet, A. Haromy, M.S. McMurtry, R.C. Bleackley, and E.D. Michelakis Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFα contributes to the pathogenesis of pulmonary arterial hypertension J. Mol. Med. (Berl.) 89 2011 771 783
55. R.W. Taylor, and D.M. Turnbull Mitochondrial DNA mutations in human disease Nat. Rev. Genet. 6 2005 389 402
56. K. Teichert-Kuliszewska, M.J. Kutryk, M.A. Kuliszewski, G. Karoubi, D.W. Courtman, L. Zucco, J. Granton, and D.J. Stewart Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension Circ. Res. 98 2006 209 217
57. D. Urboniene, I. Haber, Y.H. Fang, T. Thenappan, and S.L. Archer Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension Am. J. Physiol. Lung Cell. Mol. Physiol. 299 2010 L401 L412
58. C. Villeneuve, C. Guilbeau-Frugier, P. Sicard, O. Lairez, C. Ordener, T. Duparc, D. De Paulis, B. Couderc, O. Spreux-Varoquaux, and F. Tortosa p53-PGC-1α pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice Antioxid. Redox Signal. 18 2013 5 18
59. J.V. Virbasius, and R.C. Scarpulla Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis Proc. Natl. Acad. Sci. USA 91 1994 1309 1313
60. A.P. West, G.S. Shadel, and S. Ghosh Mitochondria in innate immune responses Nat. Rev. Immunol. 11 2011 389 402
61. W. Xu, T. Koeck, A.R. Lara, D. Neumann, F.P. DiFilippo, M. Koo, A.J. Janocha, F.A. Masri, A.C. Arroliga, and C. Jennings Alterations of cellular bioenergetics in pulmonary artery endothelial cells Proc. Natl. Acad. Sci. USA 104 2007 1342 1347
62. Q. Zhang, M. Raoof, Y. Chen, Y. Sumi, T. Sursal, W. Junger, K. Brohi, K. Itagaki, and C.J. Hauser Circulating mitochondrial DAMPs cause inflammatory responses to injury Nature 464 2010 104 107